Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cells.

Sim MW, Grogan PT, Subramanian C, Bradford CR, Carey TE, Forrest ML, Prince ME, Cohen MS.

Laryngoscope. 2016 May;126(5):E184-90. doi: 10.1002/lary.25808. Epub 2015 Dec 21.

PMID:
26690734
2.

Tumor Volumes and Prognosis in Laryngeal Cancer.

Issa MR, Samuels SE, Bellile E, Shalabi FL, Eisbruch A, Wolf G.

Cancers (Basel). 2015 Nov 10;7(4):2236-61. doi: 10.3390/cancers7040888.

3.

Sequential chemoradiation in locally advanced head and neck cancer after induction chemotherapy: an induction chemotherapy schedule more suited to a limited resource setting.

Gangopadhyay A, Nath P, Biswas J.

Ecancermedicalscience. 2015 Jun 4;9:543. doi: 10.3332/ecancer.2015.543. eCollection 2015.

4.

Low-dose fractionated radiation with induction chemotherapy for locally advanced head and neck cancer: 5 year results of a prospective phase II trial.

Gleason JF Jr, Kudrimoti M, Van Meter EM, Mohiuddin M, Regine WF, Valentino J, Kenady D, Arnold SM.

J Radiat Oncol. 2013 Mar 1;2(1):35-42.

5.

Induction of CD44 variant 9-expressing cancer stem cells might attenuate the efficacy of chemoradioselection and Worsens the prognosis of patients with advanced head and neck cancer.

Aso T, Matsuo M, Kiyohara H, Taguchi K, Rikimaru F, Shimokawa M, Segawa Y, Higaki Y, Umeno H, Nakashima T, Masuda M.

PLoS One. 2015 Mar 9;10(3):e0116596. doi: 10.1371/journal.pone.0116596. eCollection 2015.

6.

Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey.

Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD.

Cancer. 2015 May 15;121(10):1608-19. doi: 10.1002/cncr.29241. Epub 2015 Jan 13.

7.

Technical guidelines for head and neck cancer IMRT on behalf of the Italian association of radiation oncology - head and neck working group.

Merlotti A, Alterio D, Vigna-Taglianti R, Muraglia A, Lastrucci L, Manzo R, Gambaro G, Caspiani O, Miccichè F, Deodato F, Pergolizzi S, Franco P, Corvò R, Russi EG, Sanguineti G; Italian Association of Radiation Oncology..

Radiat Oncol. 2014 Dec 29;9:264. doi: 10.1186/s13014-014-0264-9.

8.

Management of advanced laryngeal cancer.

Sheahan P.

Rambam Maimonides Med J. 2014 Apr 28;5(2):e0015. doi: 10.5041/RMMJ.10149. eCollection 2014 Apr.

9.

Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancer.

Vainshtein JM, Wu VF, Spector ME, Bradford CR, Wolf GT, Worden FP.

Expert Rev Anticancer Ther. 2013 Sep;13(9):1053-64. doi: 10.1586/14737140.2013.829646. Review.

10.

Systemic therapy strategies for head-neck carcinomas: Current status.

Hoffmann TK.

GMS Curr Top Otorhinolaryngol Head Neck Surg. 2012;11:Doc03. doi: 10.3205/cto000085. Epub 2012 Dec 20.

11.

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies.

Wagner MM, Curé JK, Caudell JJ, Spencer SA, Nabell LM, Carroll WR, Bonner JA.

Radiat Oncol. 2012 Dec 21;7:219. doi: 10.1186/1748-717X-7-219.

12.
13.

Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review.

Jacobi I, van der Molen L, Huiskens H, van Rossum MA, Hilgers FJ.

Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1495-505. doi: 10.1007/s00405-010-1316-x. Epub 2010 Jun 30. Review.

Supplemental Content

Support Center